{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:40:06Z","timestamp":1784133606825,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,31]]},"DOI":"10.7759\/cureus.25513","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T08:09:01Z","timestamp":1653984541000},"source":"Crossref","is-referenced-by-count":1,"title":["Multiple Myeloma With a Rare Presentation at Preserved Uninvolved Immunoglobulins"],"prefix":"10.7759","author":[{"given":"Shunsuke","family":"Soma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.107714","article-title":"Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients","volume":"100","author":"Blimark C","year":"2015","unstructured":"Blimark C, Holmberg E, Mellqvist UH, et al.. Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients. Haematologica. 2015, 100:107-13. 10.3324\/haematol.2014.107714","journal-title":"Haematologica"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle RA","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, et al.. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006, 354:1362-9. 10.1056\/NEJMoa054494","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study","volume":"375","author":"Dispenzieri A","year":"2010","unstructured":"Dispenzieri A, Katzmann JA, Kyle RA, et al.. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study. Lancet. 2010, 375:1721-8. 10.1016\/S0140-6736(10)60482-5","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.34","article-title":"Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey","volume":"28","author":"Landgren O","year":"2014","unstructured":"Landgren O, Graubard BI, Katzmann JA, et al.. Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey. Leukemia. 2014, 28:1537-42. 10.1038\/leu.2014.34","journal-title":"Leukemia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-6196(12)60015-9","article-title":"\"Benign\" monoclonal gammopathy--after 20 to 35 years of follow-up","volume":"68","author":"Kyle RA","year":"1993","unstructured":"Kyle RA. \"Benign\" monoclonal gammopathy--after 20 to 35 years of follow-up. Mayo Clin Proc. 1993, 68:26-36. 10.1016\/s0025-6196(12)60015-9","journal-title":"Mayo Clin Proc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle RA","year":"2002","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002, 346:564-9. 10.1056\/NEJMoa01133202","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-505487","article-title":"Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden","volume":"123","author":"Turesson I","year":"2014","unstructured":"Turesson I, Kovalchik SA, Pfeiffer RM, Kristinsson SY, Goldin LR, Drayson MT, Landgren O. Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden. Blood. 2014, 123:338-45. 10.1182\/blood-2013-05-505487","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle RA","year":"2003","unstructured":"Kyle RA, Gertz MA, Witzig TE, et al.. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003, 78:21-33. 10.4065\/78.1.21","journal-title":"Mayo Clin Proc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.110","article-title":"Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma","volume":"28","author":"Kastritis E","year":"2014","unstructured":"Kastritis E, Zagouri F, Symeonidis A, et al.. Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma. Leukemia. 2014, 28:2075-9. 10.1038\/leu.2014.110","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0163-4","article-title":"Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials","volume":"32","author":"Heaney JL","year":"2018","unstructured":"Heaney JL, Campbell JP, Iqbal G, et al.. Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials. Leukemia. 2018, 32:1727-38. 10.1038\/s41375-018-0163-4","journal-title":"Leukemia"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1855345","article-title":"Deep and partial immunoparesis is a poor prognostic factor for newly diagnosed multiple myeloma patients","volume":"62","author":"Geng C","year":"2021","unstructured":"Geng C, Yang G, Wang H, et al.. Deep and partial immunoparesis is a poor prognostic factor for newly diagnosed multiple myeloma patients. Leuk Lymphoma. 2021, 62:883-90. 10.1080\/10428194.2020.1855345","journal-title":"Leuk Lymphoma"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14026","article-title":"Levels of uninvolved immunoglobulins predict clinical status and progression-free survival for multiple myeloma patients","volume":"174","author":"Harutyunyan NM","year":"2016","unstructured":"Harutyunyan NM, Vardanyan S, Ghermezi M, Gottlieb J, Berenson A, Andreu-Vieyra C, Berenson JR. Levels of uninvolved immunoglobulins predict clinical status and progression-free survival for multiple myeloma patients. Br J Haematol. 2016, 174:81-7. 10.1111\/bjh.14026","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2019.04.002","article-title":"Heavy\/light chain assay in the monitoring of multiple myeloma","volume":"51","author":"Ting HY","year":"2019","unstructured":"Ting HY, Sthaneshwar P, Bee PC, Shanmugam H, Lim M. Heavy\/light chain assay in the monitoring of multiple myeloma. Pathology. 2019, 51:507-11. 10.1016\/j.pathol.2019.04.002","journal-title":"Pathology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188988","article-title":"Immunoparesis in newly diagnosed multiple myeloma patients: effects on overall survival and progression free survival in the Danish population","volume":"12","author":"S\u00f8rrig R","year":"2017","unstructured":"S\u00f8rrig R, Klausen TW, Salomo M, et al.. Immunoparesis in newly diagnosed multiple myeloma patients: effects on overall survival and progression free survival in the Danish population. PLoS One. 2017, 12:e0188988. 10.1371\/journal.pone.0188988","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4274\/tjh.2016.0161","article-title":"The effect of suppressed levels of uninvolved immunoglobulins on the prognosis of symptomatic multiple myeloma","volume":"34","author":"Sar\u0131 M","year":"2017","unstructured":"Sar\u0131 M, Sar\u0131 S, Nal\u00e7ac\u0131 M. The effect of suppressed levels of uninvolved immunoglobulins on the prognosis of symptomatic multiple myeloma. Turk J Haematol. 2017, 34:131-6. 10.4274\/tjh.2016.0161","journal-title":"Turk J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/95828-multiple-myeloma-with-a-rare-presentation-at-preserved-uninvolved-immunoglobulins","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:20Z","timestamp":1707507380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/95828-multiple-myeloma-with-a-rare-presentation-at-preserved-uninvolved-immunoglobulins"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.25513","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,31]]}}}